Ethanol Lock for Prevention of Central Line-Associated Blood Stream Infections
Status unconfirmed · Not applicable
Conditions studied: Central Lines in ICU Patients
In brief
Vascular access via central venous lines (CVL) is essential to the care of many patients in the intensive care setting. While the value of these lines for the management of critically ill patients is generally accepted, the potential for line-associated blood stream infection is a known complication of the use of this intervention. Ethanol is an effective antimicrobial agent with activity against a broad spectrum of human pathogens. The purpose of this study is to evaluate the effectiveness of daily treatment of the catheter lumen with ethanol to prevent central line associated blood stream infections (CLABSI). The hypothesis is that this treatment will reduce the incidence of CLABSI compared to maintenance of the lines with normal saline alone.
Key facts
- Study ID
- NCT01344590
- Run by
- University of Virginia
- People needed
- 50
- Starts
- 2011-02-01
- Expected to finish
- 2012-05-01
- Last updated by the study team
- 2011-04-29
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Virginia — Charlottesville, Virginia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.